Pharmaceutical information systems and possible implementations of informed consent - developing an heuristic
BMC Medical Ethics 13 (1):30- (2012)
| Abstract | Background Denmark has implemented a comprehensive, nationwide pharmaceutical information system, and this system has been evaluated by the Danish Council of Ethics. The system can be seen as an exemplar of a comprehensive health information system for clinical use. Analysis The paper analyses 1) how informed consent can be implemented in the system and how different implementations create different impacts on autonomy and control of information, and 2) arguments directed towards justifying not seeking informed consent in this context. Results and Conclusion Based on the analysis a heuristic is provided which enables a ranking and estimation of the impact on autonomy and control of information of different options for consent to entry of data into the system and use of data from the system. The danger of routinisation of consent is identified. The Danish pharmaceutical information system raises issues in relation to autonomy and control of information, issues that will also occur in relation to other similar comprehensive health information systems. Some of these issues are well understood and their impact can be judged using the heuristic which is provided. More research is, however needed in relation to routinisation of consent | |||||||||
| Keywords | Autonomy Control Health information Health information systems Informed consent Routinisation | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,679 |
| External links |
  Try with proxy. |
| Through your library | Configure |
Similar books and articlesLarry O. Gostin (1997). Personal Privacy in the Health Care System: Employer-Sponsored Insurance, Managed Care, and Integrated Delivery Systems. Kennedy Institute of Ethics Journal 7 (4):361-376.
Sheila McLean (2010). Autonomy, Consent and the Law. Routledge-Cavendish.
Leslie Cannold (1997). "There Is No Evidence to Suggest...": Changing the Way We Judge Information for Disclosure in the Informed Consent Process. Hypatia 12 (2):165 - 184.
Asya Al-Riyami, Deepali Jaju, Sanjay Jaju & Henry J. Silverman (2011). The Adequacy of Informed Consent Forms in Genetic Research in Oman: A Pilot Study. Developing World Bioethics 11 (2):57-62.
Tom Walker (2011). Informed Consent and the Requirement to Ensure Understanding. Journal of Applied Philosophy 29 (1):50-62.
Deborah Bowman (2011). Informed Consent: A Primer for Clinical Practice. Cambridge University Press.
Maxwell Gregg Bloche (1997). Managed Care, Medical Privacy, and the Paradigm of Consent. Kennedy Institute of Ethics Journal 7 (4):381-386.
Ruth R. Faden (1997). Managed Care and Informed Consent. Kennedy Institute of Ethics Journal 7 (4):377-379.
M. Sheehan (2011). Can Broad Consent Be Informed Consent? Public Health Ethics 4 (3):226-235.
O. O'Neill (2001). Informed Consent and Genetic Information. Studies in History and Philosophy of Science Part C 32 (4):689-704.
Gil Siegal, Richard J. Bonnie & Paul S. Appelbaum (2012). Personalized Disclosure by Information-on-Demand: Attending to Patients' Needs in the Informed Consent Process. Journal of Law, Medicine and Ethics 40 (2):359-367.
Ayodele S. Jegede (2009). Understanding Informed Consent for Participation in International Health Research. Developing World Bioethics 9 (2):81-87.
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2012-11-17Total downloads0Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
